NCBI Summary
This gene encodes a member of the natural killer cell receptor C-type lectin family. The encoded protein inhibits osteoclast formation and contains a transmembrane domain near the N-terminus as well as the C-type lectin-like extracellular domain. Several alternatively spliced transcript variants have been identified for this gene. [provided by RefSeq, Oct 2010].
Protein
Protein (NP_037401)
C-type lectin domain family 2 - OCIL
C-type lectin domain family 2 member D (Lectin-like NK cell receptor) (Lectin-like transcript 1) (LLT-1) (Osteoclast inhibitory lectin)
CLEC2D
C-type lectin domain family 2 member D
Undefined
Low evidence
C-type lectin
CELEC2D
C-type - Natural Killer NK
a/b mixed / C-type lectin-like
Heparin and chondrotin sulfate A
0.245
Protein sequence and protein families (fasta) (191 amino acids) Download
MHDSNNVEKDITPSELPANPGCLHSKEHSIKATLIWRLFFLIMFLTIIVCGMVAALSAIRANCHQEPSVCLQAACPESWIGFQRKCFYFSDDTKNWTSSQRFCDSQDADLAQVESFQELNFLLRYKGPSDHWIGLSREQGQPWKWINGTEWTRQFPILGAGECAYLNDKGASSARHYTERKWICSKSDIHV
Mol* PDB structure viewerUniLectin3D
Structural models
Model Confidence:
  •    Very high (pLDDT > 90)
  •    Confident (90 > pLDDT > 70)
  •    Low (70 > pLDDT > 50)
  •    Very low (pLDDT < 50)

  AlphaFold produces a per-residue confidence score (pLDDT) between 0 and 100. Some regions with low pLDDT may be unstructured in isolation.

Oligomerization and Known Interactions
Homodimer; disulfide-linked
Annotation
Ligand
Glycan ligands from structural data
No crystal structures of complexes with glycan ligand.
Expression
Functionality temporarily unavailable.
References
NCBI References (10 PubMed Identifiers)
  • Role of LLT1 and PCNA as Natural Killer Cell Immune Evasion Strategies of HCT 116 Cells. [33288556]
  • Docetaxel suppresses immunotherapy efficacy of natural killer cells toward castration-resistant prostate cancer cells via altering androgen receptor-lectin-like transcript 1 signals. [32449811]
  • Immune Sensing of Cell Death through Recognition of Histone Sequences by C-Type Lectin-Receptor-2d Causes Inflammation and Tissue Injury. [31859049]
  • Lectin-like transcript 1 (LLT1) expression is associated with nodal metastasis in patients with head and neck cutaneous squamous cell carcinoma. [30955082]
  • Biological and Clinical Significance of Human NKRP1A/LLT1 Receptor/Ligand Interactions. [31002602]
  • Missing self-recognition of Ocil/Clr-b by inhibitory NKR-P1 natural killer cell receptors. [14990792]
  • The LLT1 receptor induces IFN-gamma production by human natural killer cells. [15104121]
  • Isolation of a human homolog of osteoclast inhibitory lectin that inhibits the formation and function of osteoclasts. [14753741]
  • Genetically linked C-type lectin-related ligands for the NKRP1 family of natural killer cell receptors. [12858173]
  • Cloning of a new lectin-like receptor expressed on human NK cells. [10541800]
UniProt Main References (7 PubMed Identifiers)
  • Characterization of alternatively spliced transcript variants of CLEC2D gene. [20843815]
  • The finished DNA sequence of human chromosome 12. [16541075]
  • The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC). [15489334]
  • Characterization of sugar binding by osteoclast inhibitory lectin. [15123656]
  • Cutting edge: lectin-like transcript-1 is a ligand for the inhibitory human NKR-P1A receptor. [16339513]
  • Four crystal structures of human LLT1, a ligand of human NKR-P1, in varied glycosylation and oligomerization states. [25760607]
  • Crystal structure of extracellular domain of human lectin-like transcript 1 (LLT1), the ligand for natural killer receptor-P1A. [25826155]
All isoforms of this gene containing a lectin domain
NP_001004419.1, NP_001184246.1, NP_037401.1, NP_001184248.1, NP_001184247.1
RNA
RNA (Transcript ID: NM_013269.6)
C-type lectin domain family 2 member D, transcript variant 1
m7G-5')ppp(5'-ACUCAUAGAAACUGGAGGCAAAAUGCAUGACAGUAACAAUGUGGAGAAAGACAUUACACCAUCUGAAUUGCCUGCAAACCCAGGUUGUCUGCAUUCAAAAGAGCAUUCUAUUAAAGCUACCUUAAUUUGGCGCUUAUUUUUCUUAAUCAUGUUUCUGACAAUCAUAGUGUGUGGAAUGGUUGCUGCUUUAAGCGCAAUAAGAGCUAACUGCCAUCAAGAGCCAUCAGUAUGUCUUCAAGCUGCAUGCCCAGAAAGCUGGAUUGGUUUUCAAAGAAAGUGUUUCUAUUUUUCUGAUGACACCAAGAACUGGACAUCAAGUCAGAGGUUUUGUGACUCACAAGAUGCUGAUCUUGCUCAGGUUGAAAGCUUCCAGGAACUGAAUUUCCUGUUGAGAUAUAAAGGCCCAUCUGAUCACUGGAUUGGGCUGAGCAGAGAACAAGGCCAACCAUGGAAAUGGAUAAAUGGUACUGAAUGGACAAGACAGUUUCCUAUCCUGGGAGCAGGAGAGUGUGCCUAUUUGAAUGACAAAGGUGCCAGUAGUGCCAGGCACUACACAGAGAGGAAGUGGAUUUGUUCCAAAUCAGAUAUACAUGUCUAGAUGUUACAGCAAAGCCCCAACUAAUCUUUAGAAGCAUAUUGGAACUGAUAACUCCAUUUUAAAAUGAGCAAAGAAUUUAUUUCUUAUACCAACAGGUAUAUGAAAAUAUGCUCAAUAUCACUAAUAACUGGGAAAAUACAAAUCAAAAUCAUAGUAAAAUAUUACCUGUUUUCAUGGUGCUAAUAUUACCUGUUCUCCCACUGCUAAUGACAUACCCGAGACUGAGUAAUUUAUAAAUAAAAGAGAUUUAAUUGACUCAUAGUUCCACAUGGCUGGGGAGGUCUUGCAAUCAUGACAGAAGGCAAAUGGGAAGCAAAGUCAUGUCUUAUGUGGUGGCAGGCAGGGGGACUUGUGCACAGGAACUCCUAUUUAUACAACCAUCAGAUAUCUUGAGACAAGAACAGUAUGGGGCUCCCUGGUGUGAUUCCGUCCUGCGCGGCUGUUCUCUGGAGCAGCAUUCAUUUAUCUUCGUCUGCCUUGUCUCCUACCUAAGUGUGUGUCGCCACCCGAUGGAAGAUUCGAUGGACAUGGACAUGAGCCCCCUGAGGCCCCAGAACUAUCUUUUCAGUUGUGAACUAAAGGCCGACAAAGAUGAUCACUUUAAGGUGGAUAAUGAUGAAAAUGAGACCAGUUAUCUUUAAGAACGGUCAGCUCAGGGGCUGGUGCAAAGGAUGAACUGCACAUUGUUGAAGCAGAGGCCAUGAAUGACGAAGGCAGUCCAAUUAAAGUAACACUGGCAACUUUGAAAAUGUCUGUACAGCCAACGGUUUCUCUUGGGGGCUUUGAAAUAACACCACCAGUGGACUUAAGGUUGAAGUGUGGUUCAGGGCCAGUGCAUAUUAGUGGACAGCACUUAGUAGCUGUGAAGGAAGGUGCAGAGUCAGAAGAUGAAGAAGAGGAGGAUGUGAAACUCUUAAGUAUAUCUGGAAAGCAGUCUGCCCCUGGAGGUGGGCAGAAAAAAGUAAAACUUGCUGCUGCUGCUGAUGAUGAUGAUGAUGAAGAUGAUGAUGAUGAUGAUGACGAGGAAGCUGAAGAAAAAGCGCCAGUGAAGAAAUCUAUACGAGAUACUCCAGCCAAAAAUGCACAAAAGUCAAAUCAGAAUGGAAAAGACUCAAAACCAUCAUCAACACCAAGAUCAAAAGGACAAGAAUCCUUCAAAAAACAGGAAAAAUCUCCUAAAACACCAAAAGGAUCUAGUUCUGUAGAAGACAUUAAAGCAAAAAUGCAAGCAAGUAUAGAAAAACGUGGUUCUCUUCCCAAAGUGGAAACCAAGUUCAUCAAUUAUGUGAAGAAUUUCUUCUGGAUGACUGACCAAGAGGCUAUUCAAGAUCUCUGGCAGUGGAGGAAGUCUCUUUAAGAAAAUAGUUUAAACAAUUUGUUAAAAAUUUUCCAUCUUAUUUCAUUUCUGUAACAGUUGAUAUCUGGCUGUCCUUUUUAUAGUGCAGAGUGAGAACUUUCCCUACCAUGUUUGAUAAAUGUUGUCCAGGUUCUAUUGCCAAGAAUGUGUUGUCCAAAAUGCCUGUUUAGUUUUUAAAGAUGGAACUCCACCCUUUGCUUGGUUUUAAGUAUGUAUGGGAUGCUAUGAUAGGACAUAGUAGUAGCAGUGGUCAGACAUGGAAAUGGUGGGGAGACAAAAGUAUACACGUGAAAUAAAACUCAGUAUUUUAAUAAAGUAAAAAAAAAAAAAAAGGUAUGGGGAAAACUGCCCCCAUAAAGCAAUUGUCUCCACCUGGCCCUGCCCUUUGCAUGUGGAGAUUAUUACAAUUCAAGGUGAAAUUUGGGUGGAGACACAACCAAACCAUAUCAGAUGGCUAUAUCAAAAAGACAAGAAAUAACAAGCAUUGGUGAGAGUGUGGAGAAGACGGAACCCUUGUACACAGUUGGUGGGAACACAGUUUGGUGCAGCCAUUAUAGAAAACGUCAUGGAGGUUCCUAAAGAAAUUAAAAAGAGAACUACCAUAUGAGCCAGCAAUCCCUUUUCCAGAUAUACACCCAAAGGAAAUGAAAUCACCACCUCAUAAAGAUAUCUGCUUUCCUGUUUAUUAUAACACAUCUUUAUUCAUAAUAGCCAAGAUACGGAACUAACUGAAGUGACCAUUAACAGAUGAAUGGAUAAAGAAAUUGUCAUAUAUAUAAAACACACACAUUAUAUACAUACAUACAUAUAUAUAUAUAUAUAAAAAAUAGAAUAUUAUUCAGCCUUGUAAAAAGAAAUCCUGUUAUGUUGGGAACAAGCCCCCCAAAAUCUGGCCAUAAACUCACCCCAAAACUGGCCAUAAACAAAAUCUCUGCAGCACUGUGACAUGUUAGUGAUGGCCAUAACACCCACGCUGGAAGGUUGUGGGUUUAUGGGAAUGAGGGCAAGGAACACCUGGCCUGCCCAGGGUGGAAAACCACUUAAAGGCGUUCUUAAGCUACAAACAAUAGCAUGAGCGAUCUGUGCCUUAAGGACAUGUUCCUGCUGCAGUUAACUAGCCCAAUCUAUUCCUUUAAUUCGGCCCAUCCCUUCAUUUCCCAUAAGGGAUACUUUUAGUUAAUUUAAUAUCUAUAGAAACAAUGCUAAUGACUGGCUUGCUGUUAAUAAAUACAUGGGUAAAUCUCUGUUCUGGGCUCUCAGCUCUGAAGGCUGUGAGACCCCUGAUUUCCCACUUCACACCUCUAUAUUUCUGUGUGUGUGUCUUUAGUUCCUCUGGCGCUGCUGGGUUAGGAUCUACCCGACUGAGCUGGUCUCAGCACUGUUAUUUGAAACAAUGUAAAUAAACCUAUAGGGUUUAUUAUAUAUACUAAGUGAAAUAAGCCAGACACAGAAAAAAAAUGUUGCAUGAUCUCACUUAUAGUGAAACUUAAAAAAAAAACCCAAAUACAUAGAAAUAGAGUAGAAUGGUGGUUACCAGAGAUGAGGAAAAUACAGAGACACAGGUCAAAAGAUACAGAGUUGCAGUUACAAAGGGUGAGUAUGUCUAGAUAUCUAACAUACAGUAUGAGGACUAUAAUAGUAUUGCACUGUGUACUGAAAACUUGAUGACAGAUUUUAGAUAUUCUUACCACACAGACAAAAAGAAAUGUAAGUAUGUGAGAUGAAGCUUAUGUUAAUUAGAUUAAGUGUAUGUACAUAAAAACAUCACAUUAUACACAUCAAAUAUAUACAAUAAAAAAGCACAUUGGGAGAUACAUGAUAAAUUUCUAUCUGCAGUUGCUAUUUGCAUUUUUAAAGGAUAUUUUUAUUUUUUAAAUUUUUAGCUGACAACUGUAUAAUUAUGGAAUACAAUGUGAUGUUCUGAUAUAUGUGUACACUAUGGAAUGAUUAAAUCAAACUAACAUUUCAUCAUCUCACAUACUUAUCAUUUUCUGUGGUGAGAACAUUUGAAAUUUAUUCUCUUGACAAUUUUGAAAGAUCCAAUACACUAUUAUUAACUAUAGUCACUAUGCUGUGCAAUAGAUCUCAAAAGCUUAUUCCUCUUAACUGAAACCUACUACCCUGUGACAUGUGGGGAACAUCUCUCUAUUCCCCAGCCCCAGUCCCUAAAUGUUGAAUACACAAUGGGGAAAAAAUAGUCUUCAAUGAAUGGUGGUGGGAAAAUUGUAUAUCCACAUGCAGAAGAAUAAAAUUGGACCCUUACCUCCUACCAUAUAUAAAAACCAACUGAAAAUCGAUUAAAGACUUAAACUGUAAAACUACUAAAAGAAAAUAUAGGGAGAAAGCUUCACAACGUUGGUCUGGGCAAUAAUUUUUGGAUUUGACCUCAAAAGUAGAUGCAACCACAGUGAAAAUAAACAAAUGAAAUUGCAUAAAAUAAAAAAUGUUUCUGCACAGCAAAGGAAAUAAUUAAUGGAGUAAAGAGACAACUUACAGAUUGGGAGAAUAUAUUUCCAAACUAUUGUUGGGGCUCAGAAACGGAUACCCUAACAUAUAGUGAUUUGACAGGUGGAACUAAAGAAGACUCGAGGUCUCUCUGACCUCCUCCUCAACCUCUGUUUCUUAAUCCUCUGUUUUCCCAGAGCACAGGAGGAAGUUCUCUGAAGUUCCUUUAUCUGCUUUAAGUUCAGACUCACCAAAUAAGAAAACAGUUAAUUCUGGUGCCUUCCAUGGGUUUUCAUUAACUGAAGUCAUAUUGUAGGAAAAAGAAUGAAGUCUCUUAACCCACCUGGAUAGAUUUUUCUCACAAACCAUUGUCUUCUCUGCAAGCCCAGUAGACUUUGUCCCAGGCCAUUUAUGUGAUCUUCACCCCAUUAAGUUCUCCCCAAAUUAUUUACUCUUCCCCCAAAAUCACCCACACUUCCCCAUCUCCCUCUCCCCUAAGGACAAGGGUAUAUCACCAUCUAUACCCCAUUGCUUGGUGGGGUGAUCACUCUGAUUCUCUGCAUGCAUUUUUAUAGAUUUGUUUGCCAUUUAUCCUAUUAAUCUGCAUUCUGUCAAUUGUGGCAAGUUAUCAGCAUAUUUUUUAACUUUUAAUUAUUCUUAAUGGAAAGACACUUCUGUAUACACUGGAAAUCUCAGGAAAUUUCUUUUUUCCUUAAGCUUAAUUGAAAUGUUUACUUUUCAGUAAAAUUUCAAGCUUGAGUAAUGUUCAUGCCUGCUUUUCAUUGAAAUAGAAUGAAAAGGUUGCACAAUAUUAUUUUCAUGAAAUUACUUCUAGUAUAAUUCUGAAUAAACACUUUGAAAGGCAGUGAACUGUAAA-3'- Poly-A tail
  • Coding region
DNA
DNA (Gene ID: 29121)
C-type lectin domain family 2 member D
strand +
LLT1, CLAX, OCIL
NCBI CDS gene sequence (576 bp)
5'-ATGCATGACAGTAACAATGTGGAGAAAGACATTACACCATCTGAATTGCCTGCAAACCCAGGTTGTCTGCATTCAAAAGAGCATTCTATTAAAGCTACCTTAATTTGGCGCTTATTTTTCTTAATCATGTTTCTGACAATCATAGTGTGTGGAATGGTTGCTGCTTTAAGCGCAATAAGAGCTAACTGCCATCAAGAGCCATCAGTATGTCTTCAAGCTGCATGCCCAGAAAGCTGGATTGGTTTTCAAAGAAAGTGTTTCTATTTTTCTGATGACACCAAGAACTGGACATCAAGTCAGAGGTTTTGTGACTCACAAGATGCTGATCTTGCTCAGGTTGAAAGCTTCCAGGAACTGAATTTCCTGTTGAGATATAAAGGCCCATCTGATCACTGGATTGGGCTGAGCAGAGAACAAGGCCAACCATGGAAATGGATAAATGGTACTGAATGGACAAGACAGTTTCCTATCCTGGGAGCAGGAGAGTGTGCCTATTTGAATGACAAAGGTGCCAGTAGTGCCAGGCACTACACAGAGAGGAAGTGGATTTGTTCCAAATCAGATATACATGTCTAG-3'
NCBI CDS gene sequence with introns (location: 9669735.. 9694874) (25140 bp)Download
NCBI CDS gene sequence with introns, 5'UTR and 3'UTR (location: 9669713.. 9699553) (29841 bp)Download
NCBI gene sequence (location: [9669713 - 1000].. 9699553) (30841 bp)Download
Cite How to cite